The life science sector is in an intriguing state of change. Over the past 30-40 years numerous strategic decisions have been made in an attempt to stay ahead of the game, and respond to changing pressures in the industry. Organisations are at another crucial point where it is no longer good enough to try and improve the existing ways of working, but a complete re-think is needed to challenge the fundamental operating model. Innovative thinking towards R&D, supply chain, and customer service will be crucial in how companies re-define themselves in a very fast changing environment.
Crimson & Co understands the importance of aligning commercial and operational teams, with a clear focus on understanding trade-offs across the business. With this in mind, we believe supply chain directors should be challenging themselves in these areas:
Have we got the right operating model? Is the focus in the right areas, and is their integration across the business units & functions
How do we have one supply chain, with many different ways of operating? The demand and supply characteristics vary drastically across products and supply chains, but has this been factored into a wider supply chain strategy with synergies identified and executed where appropriate
Are trade off decisions being made with a full end to end understanding of the supply chain?
This organisation was created following the recent merger of four European pharmaceuticals companies (Italian, German, and two UK companies). There was a cost saving target of $4million from ‘indirect’ materials through targeted aggregation of demand across the companies via harmonised processes, specifications and suppliers. Crimson & Co was engaged to set up and manage the project from assessment to delivery of efficiencies.
The clinical research department of a leading pharmaceutical company contracted each clinical trial on a trial-by-trial basis with no procurement involvement. Processes differed between clinical leads for identifying and fulfilling requirements. There was no standard contract or approach. Crimson & Co led a strategic sourcing process to reduce cost whilst enabling longer-term arrangements with key providers.
This European pharmaceutical had 12 major agency suppliers (with spend greater than €100k), making up a total spend of €3.7m. Processes for identifying and fulfilling requirements differed across sites and sometimes across departments. Crimson & Co led a category team based approach, as part of a larger strategic sourcing project.
We transformed this client by: leading a rapid impact programme that successfully raised ‘on time in full’ service levels to customers from 8% to over 90% in six months; reducing lead times significantly through reduction in the planning timeframes; and, developing a strategy for their distribution infrastructure that provided better service levels at a lower operational cost.